|
Danielle Brooks PhD
Pharmacology/Toxicology Acting Team Lead, Office of Therapeutic Products (OTP)
Food Drug and Administration (FDA)
USA
|
Danielle Brooks is an Acting Team Lead in the Division of Pharmacology/Toxicology 1 in the Office of Therapeutic Products in the Center for Biologics Evaluation and Research at the FDA. She received her Ph.D. in Biomedical Sciences with a concentration in Cancer and Developmental Biology at The University of Tennessee Health Science Center in Memphis, TN. Following her graduate training, Dr. Brooks completed her post-doctoral training in the Women’s Malignancies Branch of the National Cancer Institute. In 2017, she was selected for a fellowship in the NCI-FDA Interagency Oncology Task Force Fellowship program where she participated in product quality research and review of cellular therapies in the Cellular and Tissues Therapies Branch. At the completion of her fellowship in 2018, Dr. Brooks joined the Pharmacology/Toxicology Branch where she now focuses on overseeing the review of preclinical toxicology and pharmacology data to support the safety of cell and gene therapies, tissue-engineered products, devices and combination products.